Search Results 1401-1410 of 19400 for hemoglobin

  1. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9.0 g/dL obtained ≤ 7 days prior to registration; International normalized ratio (INR) and partial thromboplastin (PTT) ≤ 3.0 x ULN ...

  2. A Study To Evaluate The Effectiveness And Safety Of Vibegron Administered Orally For 12 Weeks To Women With Irritable Bowel Syndrome - Mayo Clinic

    Uncontrolled diabetes mellitus defined by a hemoglobin A1C level > 8%. Significant psychiatric or psychologic disorder that would preclude meaningful ...

  3. Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

    Obtained =< 14 days prior to registration: Hemoglobin >= 8.0 g/dL; Obtained =< 14 days prior to registration: Total bilirubin =< 1.5 x upper limit of normal ...

  4. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

    Hemoglobin ≥ 8 g/dL or ≥ 5 mmol/L;; Alanine aminotransferase (ALT), aspartate aminotransferase (AST) ≤ 3 x upper limit of normal (ULN) and total bilirubin ...

  5. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Night sweats without evidence of infection. Evidence of progressive marrow failure as manifested by the development of or worsening anemia (i.e., hemoglobin ...

  6. A Study To Assess The Feasibility And Safety Of Intratumoral Diffusing Alpha Emitters For The Treatment Of Recurrent Glioblastoma - Mayo Clinic

    ... Hemoglobin (Hgb) ≥ 9 g/dL. Patients must have the following blood chemistry levels at initial screening obtained ≤ 14 days prior to starting treatment AST ...

  7. A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 - Mayo Clinic

    Hemoglobin ≥ 10 g/dL (eligibility level for hemoglobin may be met by transfusion). Renal: Serum creatinine < 1.5 x upper limit of normal (ULN) or ...

  8. Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy - Mayo Clinic

    Hemoglobin (HgB) > 9.0 gm; Absolute neutrophil count (ANC) ≥ 1500 cells/L; Platelets ≥ 100,000 u/L; Creatinine ≤ 1.5 x upper limit of normal (ULN); Serum ...

  9. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Hemoglobin > 9 g/dL, transfusion permitted; Total bilirubin < 1.5 x upper limit of normal (ULN) (or < 3 x ULN for subjects with Gilbert's syndrome) ...

  10. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301) - Mayo Clinic

    Pulmonary function: Diffusing capacity of the lung for carbon monoxide (DLCO) ≥ 50% (adjusted for hemoglobin), and forced expiratory volume in one second ...